Osteopore Limited logo

Osteopore Limited (OSX)

Market Closed
ASX ASX
- Market Cap
- P/E Ratio
- Div Yield
5,810 Volume
0 Eps
Want to track OSX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

OSX is not paying dividends to its shareholders.
The last earnings report, released on Feb 26, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Osteopore Limited has completed 2 stock splits, with the recent split occurring on Feb 23, 2024.
The company's stock is traded on one exchange.

Osteopore Limited (OSX) FAQ

On which exchange is it traded?

Osteopore Limited is listed on ASX.

What is its stock symbol?

The ticker symbol is OSX.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Osteopore Limited ever had a stock split?

Osteopore Limited had 2 splits and the recent split was on Feb 23, 2024.

Osteopore Limited Profile

Industrial Conglomerates Industry
Industrials Sector
Shaheed Bailey CEO
ASX Exchange
Q71630109 CUSIP
US Country
- Employees
- Last Dividend
15 Mar 2023 Last Split
- IPO Date

Overview

Innovest Global, Inc., based in Chesterland, Ohio, operates across multiple sectors, including commercial and industrial, energy, and biotechnology and health services. Initially founded as Aurum Resource and Asset Management, Inc., the company underwent a name change to Innovest Global, Inc. in January 2017. Since its incorporation in 1999, Innovest Global has diversified its offerings to cover a broad range of services and products, from engineering solutions to health innovations, aiming to reduce energy costs for businesses and develop groundbreaking medical treatments.

Products and Services

  • Curtain Wall Systems

    Innovest Global designs, engineers, tests, and manufactures curtain wall systems, providing innovative solutions for the exterior cladding of buildings. These systems are essential for the aesthetic and functional aspects of commercial and high-rise residential buildings, offering protection against weather while enhancing natural light inside.

  • Personal Protection Equipment (PPE), Apparel, and Safety Supplies

    The company plays a crucial role in supplying various industries with critical safety materials, including personal protection equipment and apparel. These products are vital for ensuring the safety and health of workers across different sectors.

  • Call Center Services

    Offering both inbound and outbound call services, Innovest Global caters to businesses requiring customer service support, telemarketing, and other call-based services. This division allows companies to outsource their customer interaction operations efficiently.

  • Exterior Building Products

    Through negotiating and purchasing an array of exterior building products, Innovest Global supports construction and renovation projects by providing high-quality materials essential for modern building requirements.

  • Energy Services

    The company's energy services are geared towards helping businesses reduce their overall energy costs. This is facilitated through energy efficiency consultations and implementing cost-saving measures like LED lighting products. Innovest Global also operates as an independent energy broker, assisting clients in navigating their energy options to find the best solutions.

  • LED Lighting

    As part of its energy-efficient solutions, Innovest Global offers LED lighting products designed to reduce energy consumption and operational costs. These products are well-suited for both commercial and residential applications, promoting environmental sustainability and lower utility bills.

  • Immunotherapeutic Development for Glioblastoma Multiforme

    Innovest Global is at the forefront of biotechnological research through its development of immunotherapeutic treatments aimed at glioblastoma multiforme, a highly aggressive form of brain cancer. This cutting-edge research highlights the company’s commitment to advancing healthcare and providing novel treatments for serious diseases.

Contact Information

Address: 8834 Mayfield Road
Phone: 216 815 1122